These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25271100)

  • 1. Protein post-translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms.
    Salazar VA; Rubin J; Moussaoui M; Pulido D; Nogués MV; Venge P; Boix E
    FEBS J; 2014 Dec; 281(24):5432-46. PubMed ID: 25271100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
    Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
    Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
    Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
    Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.
    Pulido D; Moussaoui M; Andreu D; Nogués MV; Torrent M; Boix E
    Antimicrob Agents Chemother; 2012 May; 56(5):2378-85. PubMed ID: 22330910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications.
    Trulson A; Byström J; Engström A; Larsson R; Venge P
    Clin Exp Allergy; 2007 Feb; 37(2):208-18. PubMed ID: 17250693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.
    Torrent M; Navarro S; Moussaoui M; Nogués MV; Boix E
    Biochemistry; 2008 Mar; 47(11):3544-55. PubMed ID: 18293932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein.
    Eriksson J; Woschnagg C; Fernvik E; Venge P
    J Leukoc Biol; 2007 Dec; 82(6):1491-500. PubMed ID: 17726151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
    Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
    FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil cationic protein (ECP) is processed during secretion.
    Woschnagg C; Rubin J; Venge P
    J Immunol; 2009 Sep; 183(6):3949-54. PubMed ID: 19692640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asparagine-linked glycans determine the cytotoxic capacity of eosinophil cationic protein (ECP).
    Rubin J; Venge P
    Mol Immunol; 2013 Oct; 55(3-4):372-80. PubMed ID: 23597768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
    Singh A; Batra JK
    Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
    Torrent M; Nogués MV; Boix E
    J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic Activities of Eosinophil Cationic Protein and Eosinophil-derived Neurotoxin: In Silico Analysis.
    De Oliveira PC; De Oliveira Lopes D; Do Vale Coelho IE; Pereira MC
    Cancer Genomics Proteomics; 2015; 12(6):397-402. PubMed ID: 26543086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.
    Torrent M; Badia M; Moussaoui M; Sanchez D; Nogués MV; Boix E
    FEBS J; 2010 Apr; 277(7):1713-25. PubMed ID: 20180804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antipathogen activities of eosinophil cationic protein.
    Boix E; Torrent M; Sánchez D; Nogués MV
    Curr Pharm Biotechnol; 2008 Jun; 9(3):141-52. PubMed ID: 18673279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.
    Torrent M; Pulido D; de la Torre BG; García-Mayoral MF; Nogués MV; Bruix M; Andreu D; Boix E
    J Med Chem; 2011 Jul; 54(14):5237-44. PubMed ID: 21696142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
    Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
    Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants of the eosinophil cationic protein antimicrobial activity.
    Boix E; Salazar VA; Torrent M; Pulido D; Nogués MV; Moussaoui M
    Biol Chem; 2012 Aug; 393(8):801-15. PubMed ID: 22944682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound carboxypeptidase E facilitates the entry of eosinophil cationic protein into neuroendocrine cells.
    Wu CM; Chang HT; Chang MD
    Biochem J; 2004 Sep; 382(Pt 3):841-8. PubMed ID: 15233624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of human eosinophil cationic protein by an epitope-specific antibody.
    Boix E; Carreras E; Nikolovski Z; Cuchillo CM; Nogués MV
    J Leukoc Biol; 2001 Jun; 69(6):1027-35. PubMed ID: 11404391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.